What a great week for At-211!
We had a great time at the NOAR group meeting here in Gothenburg. Fantastic to see academia and industry collaborating in order to optimise the development and commercialisation of astatine-based radiopharmaceuticals in Europe.
A big thank you to the organisers for also inviting us to take part in the industry pannel discussion alongside Novartis, Atonco, IBA, Ionetix Corporation and Precirix.
The future of At-211 is bright!
